Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Chemical Leukoderma from Daytrana Skin Patch Causes Permanent Scarring July 2, 2015 Austin Kirk Add Your CommentsFollowing recent FDA warnings about the risk of chemical leukoderma from Daytrana patch side effects, many users are recognizing that the loss of skin color following repeated application of the attention deficit and hyperactivity disorder (ADHD) skin patch may be permanent.ย Daytrana (methylphenidate transdermal system) is a once-daily medicated patch, which was initially approved by the FDA in 2006 for treatment of ADHD. However, many users have suffered skin pigment changes after wearing the patch, known as chemical leukoderma.While the condition is not life-threatening and is primarily considered a cosmetic skin problem, chemical leukoderma causes the skin pigment cells to either die or cease functioning, often resulting in permanent skin color changes or scarring.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONLast month, the FDA issued the first warnings about the risk of chemical leukoderma from the Daytrana skin patch side effects, indicating that the manufacturers will be required to update the warning label for the ADHD drug.According to the drug safety communication issued by the federal regulatory agency, the Daytrana skin color changes often occur where the patch was repeatedly applied or rotated, but the problems have also been reported on areas of the body where the patch was never applied.Reports of skin color changes on Daytrana appeared anywhere from two months to four years after first use the ADHD patch, but the FDA indicates that the Daytrana scarring was permanent in all cases.Chemical leukoderma is similar to vitiligo, which may be caused by autoimmune disorders or genetics. The skin problems are most often associated with exposure to certain chemicals, but much still remains unknown about the condition.In cases where the condition is linked to chemical exposure, it is believed that the cells which create melanin, or skin pigment, known as melanocytes are damaged. This results in patches of white skin or skin with diminished color.In some cases, the use of immunomodulator creams can restore skin color. In addition, some research has explored the combination of vitamin B12, folic acid supplements and sun exposure as a potential method of restoring skin color. However, most cases appear to be permanent.Daytrana Skin Patch ProblemsFollowing the recent FDA warning, a number of lawyers are reviewing potential Daytrana chemical leukoderma lawsuits for individuals who have experienced skin color changes or other scarring problems from the ADHD patch.Given the wide availability of other treatments for ADHD, individuals diagnosed with chemical leukoderma from Daytrana may not have decided to use the ADHD skin patch treatment if they had been aware of the potential risk that they may suffer permanent skin color changes or scars.Since it was introduced, the Daytrana patch has been linked to a number of different health concerns.In a January 2013 report by the Institute for Safe Medication Practices (ISMP), which evaluates adverse event reports submitted to the FDA, more than 1,000 incidents involving problems with Daytrana patch were identified in the second quarter of 2012 alone. According to the group, adverse events associated with Daytrana over the four calendar quarters ending in the second quarter of 2012, exceeded those associated with any other drug monitored by ISMP.During that time period, out of all of the ADHD medications on the market, Daytrana accounted for only 3% of sales, but 99% of the complaints received by the FDA, leading ISMP reviewers to suggest that the FDA should consider issuing a Daytrana recall.Complaints included children suffering erythema, irritation, rashes, pruritus, burns, erosions, swelling vesicles, urticaria, and involuntary muscle movements. At least one case resulted in severe injury and hospitalization.About half of the Daytrona side effects identified were linked to drug administration problems, with many parents indicating that problems removing the adhesive backing led to the patch falling off or causing trouble with applying it to their child. There were also 89 cases of drug prescribing error.The cases of involuntary movements were of particular concern, as in clinical trials there was at least one case where the childโs involuntary movements never resolved. The involuntary movements, often referred to as tardive dyskinesia, are a common complaint among some stimulants, but the ISMP report notes that health experts at the FDA are concerned that Daytrana tardive dyskinesia symptoms seem to appear more often than with other ADHD drugs.The complaints are nothing new for Daytrana. The first distributor, Dublin, Ireland-based Shire, gave up on the product in 2010, after 10 Daytrana recalls were issued since it was first approved in the United States. The patchโs distribution was taken over directly by Noven Pharmaceuticals, which has issued two recalls since then, one in March 2011 and another in September 2011. The problems with the adhesive being stuck to the protective liner was frequently the cause of the recalls.Additionally, in December 2013, the FDA issued another warning regarding a number of ADHD drugs, including Daytrana, linking them to long-lasting, and potentially dangerous, erections, known as priapism. Tags: ADHD, ADHD Drug, Chemical Leukoderma, Daytrana, Skin ReactionsMore Daytrana Lawsuit Stories ADHD Drug Use Increasing Among Young Women, Trend Carries Pregnancy Risks: CDC January 23, 2018 Daytrana, Concerta Side Effects May Increase Risk of Heart Defects With Pregnancy Use: Study December 21, 2017 ADHD Drug Side Effects May Cause Heart Rhythm Problems in Some Children: Study June 3, 2016 2 Comments lisa May 2, 2017 my daughter has experienced skin coming off when taking the patch off, burning,itching. she now has skin discoloration. she has had rapid heart beat and she cannot gain any weight. i believe the manufacturer should be held liable for this happening. then the manufacturer does not notify anyone about a recall, what is going on with these people. it shocked me to know there was a recall back in 2011 and then 2 more, this is wrong on there part..she suffers while they make millions of dollars? what if were your kid?? i want to hear from someone, (manufacturer anyone why they have continued this medication for the horrible side effects/// Lisa July 17, 2015 I came to know that Long-term use of Daytrana can slow a child’s growth. Tell your doctor if the child using Daytrana is not growing or gaining weight properly. Do not use Daytrana on a child younger than 6 years old without the advice of a doctor.[http://www.drugs.com/daytrana.html] X/TwitterThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026) Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026) Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)
Daytrana, Concerta Side Effects May Increase Risk of Heart Defects With Pregnancy Use: Study December 21, 2017
Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)
Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026)
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)